Pharmacoepidemiology Impact Factor
The impact issue of Pharmacoepidemiology journal could be a live reflective the typical variety of citations to recent
articles printed within the journal. It’s often used as a proxy for the relative importance of a journal at intervals its field, with
journals with higher impact factors deemed to be additional vital than those with lower ones. The impact issue was devised by Eugene United States President, the founding father of the Institute for Scientific info Pharmacoepidemiology Impact factors area unit calculated yearly ranging from 2013 for those
journals that area unit indexed within the Journal Citation Reports. A journal will adopt editorial policies to extend its impact issue. As an example,
journals might publish a bigger share of review
articles that typically area unit cited over analysis reports. So review
articles will raise the impact issue of the journal and review
journals can so usually have the best impact factors in their several fields. Some journal editors set their submissions policy to "by invite only" to ask solely senior scientists to publish "citable" papers to extend the journal impact issue.
Journals might also arrange to limit the quantity of "citable items"—i.e., the divisor of the impact issue equation either by declining to publish
articles that area unit unlikely to be cited or by fixing
articles in hopes that Thomson Scientific won't see it a "citable item". As results of negotiations over whether or not things area unit "citable", impact issue variations of over three hundredth are ascertained. Apparently, things thought-about to be uncitable and so aren't incorporated in impact issue calculations will, if cited, still enter into the dividend a part of the equation despite the benefit with that such citations can be excluded. This result is tough to gauge, for the excellence between editorial comment and short original
articles aren’t perpetually obvious. as an example, letters to the editor might confer with either category.
High Impact List of Articles
-
Modulation of curcumin on PERK- CHOP signaling pathway in pancreas of type 2 diabetic rats
Kaijian Hou*, Kapil Kumar, Barkat Ali Khan, Xuhuang Wang, Chao Chen, Bangtai Wu & Yuanyuan Guo
Research Article: Pharmaceutical Bioprocessing
-
Modulation of curcumin on PERK- CHOP signaling pathway in pancreas of type 2 diabetic rats
Kaijian Hou*, Kapil Kumar, Barkat Ali Khan, Xuhuang Wang, Chao Chen, Bangtai Wu & Yuanyuan Guo
Research Article: Pharmaceutical Bioprocessing
-
Cell therapies: why scale matters
Qasim A Rafiq
Editorial: Pharmaceutical Bioprocessing
-
Cell therapies: why scale matters
Qasim A Rafiq
Editorial: Pharmaceutical Bioprocessing
-
The future for biosensors in biopharmaceutical production
Daniel G Bracewell and Karen M Polizzi
Commentary: Pharmaceutical Bioprocessing
-
The future for biosensors in biopharmaceutical production
Daniel G Bracewell and Karen M Polizzi
Commentary: Pharmaceutical Bioprocessing
-
Pharmaceutical microbiology
Tim Sandle
Special Interview: Pharmaceutical Bioprocessing
-
Pharmaceutical microbiology
Tim Sandle
Special Interview: Pharmaceutical Bioprocessing
-
Molecular farming of pharmaceutical antibodies from tobacco hair roots
Jessica Thorne
News and Views: Pharmaceutical Bioprocessing
-
Molecular farming of pharmaceutical antibodies from tobacco hair roots
Jessica Thorne
News and Views: Pharmaceutical Bioprocessing
Relevant Topics in Clinical